Charles Hitson
Internal Medicine · Griffin, GANPI 1407850480
Payments from drug & device makers
Across 215 payments — averaging $14.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$483
- Amgen$402
- Pfizer$344
- AstraZeneca$332
- Amarin Pharma, Inc.$214
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$132
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,04297%
- Education$1063%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 29 | $483 |
| Amgen | 31 | $402 |
| Pfizer | 27 | $344 |
| AstraZeneca | 24 | $332 |
| Amarin Pharma, Inc. | 10 | $214 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $132 |
| Johnson & Johnson | 10 | $128 |
| Novo Nordisk | 8 | $120 |
| AbbVie(2 entities) | 8 | $119 |
| Biohaven Pharmaceuticals, Inc. | 6 | $84 |
| Sunovion Pharmaceuticals Inc. | 9 | $79 |
| Boehringer Ingelheim | 5 | $79 |
| Biogen | 3 | $68 |
| Mylan Specialty L.p. | 4 | $58 |
| Lilly USA, LLC | 4 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Avanir Pharmaceuticals, Inc. | 2 | $35 |
| Boston Scientific | 2 | $35 |
| Genentech USA, Inc. | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Merck | 2 | $27 |
| Novartis | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Shire North American Group Inc | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Bayer | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Antares Pharma, Inc. | 1 | $13 |
| Clarus Therapeutics Inc. | 1 | $12 |
| GSK | 1 | $12 |
| Nevro Corp. | 1 | $12 |
| Medtronic | 1 | $12 |
| Smith+Nephew | 1 | $11 |
How this compares
$3,148 in reported general payments places this provider in the 80th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Griffin
- Dwayne WatkinsGriffin$1.2M
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.